In order to establish what is wanted: disruption of an outbreak and the cut down of the replication value below 1.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2768923
So we will have to see what that will mean for the commercialisation of an „ADO test“. Shall it see the light of commercialisation.
No question though that any shareprice hype could make the so called „investors“ in here happy.
80% Accuracy is sufficient for a Rapid Covid Antigen Test
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.36M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $33.18K | 1.658M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 2717347 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 723484 | 6 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| ADO (ASX) Chart |